Jim Simons
STOK icon

Jim Simons’s Stoke Therapeutics STOK Stock Holding History

Jim Simons’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-178,300
Closed -$1.19M – 3885
2025
Q1 		$1.19M Buy
178,300
+49,257
+38% +$459K ﹤0.01% 2303
2024
Q4 		$1.42M Buy
+129,043
New +$1.59M ﹤0.01% 2284
2024
Q3 		– Sell
-11,200
Closed -$151K – 3873
2024
Q2 		$151K Sell
11,200
-7,900
-41% -$107K ﹤0.01% 3105
2024
Q1 		$258K Buy
+19,100
New +$116K ﹤0.01% 3140
2023
Q3 		– Sell
-42,300
Closed -$450K – 4094
2023
Q2 		$450K Sell
42,300
-23,400
-36% -$249K ﹤0.01% 2930
2023
Q1 		$547K Sell
65,700
-38,900
-37% -$351K ﹤0.01% 2837
2022
Q4 		$965K Sell
104,600
-22,200
-18% -$231K ﹤0.01% 2553
2022
Q3 		$1.63M Sell
126,800
-27,100
-18% -$432K ﹤0.01% 2163
2022
Q2 		$2.03M Buy
153,900
+141,800
+1,172% +$2.15M ﹤0.01% 2183
2022
Q1 		$255K Buy
+12,100
New +$242K ﹤0.01% 3542
2021
Q4 		– Sell
-82,800
Closed -$2.11M – 4214
2021
Q3 		$2.11M Buy
82,800
+1,500
+2% +$41.8K ﹤0.01% 2046
2021
Q2 		$2.74M Buy
81,300
+29,100
+56% +$1.03M ﹤0.01% 2033
2021
Q1 		$2.03M Buy
+52,200
New +$2.97M ﹤0.01% 2216

Other funds holding STOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ST
Skorpios Trust Limassol, Cyprus $53.2M AUM 90.96% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jim Simons's STOK Position: Q2 2025 in Review

Jim Simons sold out of Stoke Therapeutics (STOK) in Q2 2025, closing a stake of 178,300 shares — an estimated $1.19M sold.

Jim Simons first reported a position in STOK in Q1 2021 and held it in 13 quarters. The position peaked at $2.74M in Q2 2021. 133 funds tracked by Wall St. Rank hold STOK as of Q2 2025.

  • Jim Simons reported no remaining Stoke Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Jim Simons sold 178,300 Stoke Therapeutics shares in Q2 2025, an estimated $1.19M.
  • Jim Simons first reported a position in Stoke Therapeutics in Q1 2021 and held it in 13 quarters.
  • Jim Simons's Stoke Therapeutics position peaked at $2.74M in Q2 2021.
  • 133 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2025.

Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.